Funding Opportunity PAR-18-641 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to facilitate research on the perceptual and cognitive processes underlying the performance of cancer image observers in radiology and pathology, in order to improve the accuracy of cancer detection and diagnosis.

Funding Opportunity PAR-18-640 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to facilitate research on the perceptual and cognitive processes underlying the performance of cancer image observers in radiology and pathology, in order to improve the accuracy of cancer detection and diagnosis.

Funding Opportunity RFA-ES-18-004 from the NIH Guide for Grants and Contracts. The NIEHS Revolutionizing Innovative, Visionary Environmental health Research (RIVER) program seeks to provide support for the majority of the independent research program for outstanding investigators in the Environmental Health Sciences, giving them intellectual and administrative freedom, as well as sustained support to pursue their research in novel directions in order to achieve greater impacts. The program seeks to identify individuals, regardless of career stage, with a potential for continued innovative and impactful research and combine their existing investigator-initiated research into a single award with a duration of up to eight years and direct costs of $600,000 and potentially up to $750,000 based on current NIEHS funding to be consolidated into the award.

Funding Opportunity RFA-NS-18-015 from the NIH Guide for Grants and Contracts. The purpose of the FOA is to support the structural characterization of protein species associated with Alzheimer's Disease Related Dementias (ADRDs) through the utilization of cryo-electron microscopy (cryo-EM) and cryo-electron tomography (cryo-ET) of proteins expressed in human tissue and cell sources. Studies in response to this RFA should also include the development of research tools and resources to further characterize/validate the protein species. This FOA is in response to the Alzheimer's Disease Related Dementias (ADRD) challenges outlined in the 2016 update to the National Plan to Address Alzheimer's Disease.

Notice NOT-HL-18-582 from the NIH Guide for Grants and Contracts

In computational biology, bioinformatics, computer science, machine learning, statistics, or engineering is required....
From University of Wisconsin–Madison - Tue, 06 Feb 2018 23:08:04 GMT - View all Madison, WI jobs

Salary Depends on Experience: Dana Farber Cancer Institute: Computational Lead Scientist - Translational Immunogenomics Lab Boston, Massachusetts (US)

Funding Opportunity PA-18-634 from the NIH Guide for Grants and Contracts. The NIDA Small Research Grant Program supports small research projects that can be carried out in a short period of time with limited resources. This program supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. This Funding Opportunity Announcement requires that at least 1 clinical trial be proposed. The proposed project must be related to the programmatic interests of NIDA.

Funding Opportunity PAR-18-633 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages cooperative agreement applications for implementation of investigator-initiated, high-risk clinical trials and mechanistic studies associated with high-risk clinical trials. Mechanistic work in clinical trials may be of great value because it promotes the understanding of human diseases and the development of future therapeutic modalities. Investigators are encouraged to visit the NIAID website for additional information about the research mission and high-priority research areas of the NIAID (https://www.niaid.nih.gov/research/role). Only one clinical trial may be proposed in each NIAID Clinical Trial Implementation Cooperative Agreement (U01) application.

Funding Opportunity PAR-18-632 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to implement investigator-initiated clinical trials related to the research mission of the NIAID. This program provides support for hypothesis-driven, milestone-driven clinical trials. Although clinical trials not considered high-risk may be proposed, this program encourages high-risk clinical studies. High-risk does not imply human subject or patient risk, but rather defines a study that contains one or more of the following unique features: involves non-routine interventions, administration of an unlicensed product, or administration of a licensed product for an unapproved indication. Mechanistic studies are also encouraged and can be proposed under this program. However, not more than one clinical trial should be proposed within each application. The NIAID has a robust infrastructure for conducting clinical studies that includes independently managed resources provided through grants, cooperative agreements, and contracts, as well as resources that are integrated within existing NIAID-supported clinical trial networks. Proposed clinical trials may use NIAIDs independent infrastructure for clinical studies, however, support will not be provided for studies that propose to use dedicated resources that are part of a NIAID-supported clinical trial network.

Funding Opportunity PA-18-635 from the NIH Guide for Grants and Contracts. The purpose of the Academic Research Enhancement Award (AREA) program is to stimulate research in educational institutions that provide baccalaureate or advanced degrees for a significant number of the Nation's research scientists, but that have not been major recipients of NIH support. AREA grants create opportunities for scientists and institutions otherwise unlikely to participate extensively in NIH research programs to contribute to the Nation's biomedical and behavioral research effort. AREA grants are intended to support small-scale research projects proposed by faculty members of eligible, domestic institutions, to expose undergraduate and/or graduate students to meritorious research projects, and to strengthen the research environment of the applicant institution.

Negotiable: Paramount Recruitment: Statistical Epidemiologist/ Senior Scientist Cambridge There is a great opportunity for a statistical epidemiologist to conduct real-world statistical analyses working with a world-leading bioinformatics organisation based in Cambridge. A successful appl Cambridge, England

Areas of expertise may include bioinformatics, computational biology, computer vision, systems biology, synthetic biology, structural biology, biophysics,...
From University of Wyoming - Tue, 06 Feb 2018 08:10:14 GMT - View all Laramie, WY jobs

Participate in Bioinformatics testing, validation, and analysis. With general supervision, perform routine and complex bioinformatics analysis of NGS....
From Medical College of Wisconsin - Mon, 05 Feb 2018 21:08:09 GMT - View all Milwaukee, WI jobs

Funding Opportunity RFA-AG-18-030 from the NIH Guide for Grants and Contracts. The over-arching purpose of this FOA is to help to lay the groundwork for pragmatic trials and real-world implementation of Alzheimers disease and related dementias (ADRD) care and caregiving interventions by supporting early-Stage (Stage I, II, III of the NIH Stage Model) behavioral intervention development clinical trials aimed at adapting/modifying interventions for the real world, examining the principles underlying these interventions, developing methods to ensure real-world fidelity of delivery, and developing training procedures for the people in the community who will be delivering the interventions.

Notice NOT-DK-18-010 from the NIH Guide for Grants and Contracts

Negotiable: Paramount Recruitment: Senior Bioinformatics Analyst 100,000 Genomes Project - Central London - Statistical Genetics! Paramount are working in partnership with Genomics England to expand their team in order to deliver success with the 100,000 Genomes Project. London, England

Competitive Salary: EMBL: BioinformaticianLocation:EMBL-EBI Hinxton near Cambridge, UK Staff Category:Staff memberContract Duration:1 year and 6 months initially (renewable)Grading:5 (monthly salary starting at £2,552 after tax). For more information about pay and benefits click Hinxton, Cambridgeshire, England

Funding Opportunity RFA-MH-19-130 from the NIH Guide for Grants and Contracts. The NIMH Biobehavioral Research Awards for Innovative New Scientists (BRAINS) award is intended to support the research and research career advancement of outstanding, exceptionally productive scientists who are in the early, formative stages of their careers and who plan to make a long term career commitment to research in specific mission areas of the NIMH. This award seeks to assist these individuals in launching an innovative clinical, translational, basic or services research program that holds the potential to profoundly transform the understanding, diagnosis, treatment, or prevention of mental disorders. The NIMH BRAINS program will focus on the research priorities and gap areas identified in the NIMH Strategic Plan and the Research Domain Criteria (RDoC) project.

Funding Opportunity PA-18-631 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to provide a vehicle for Small Business Concerns (SBCs) submitting Small Business Innovation Research (SBIR) grant applications for investigator-initiated exploratory clinical trials to the National Institute of Biomedical Imaging and Bioengineering (NIBIB). This Funding Opportunity Announcement requires that at least 1 clinical trial be proposed. The proposed project must be related to the programmatic interests of the NIBIB. For this Funding Opportunity Announcement, the NIBIB will only support SBIR applications proposing early-stage clinical trials through Phase I, first-in-human, safety, feasibility or other small clinical trials that inform early-stage technology development. The NIBIB will not support applications proposing Phase II, III, IV or pivotal clinical trials or trials in which the primary outcome is efficacy, effectiveness or a post-market concern.